• Source: Nidufexor

Nidufexor (LMB-763) is a drug which acts as a partial agonist of the farnesoid X receptor (FXR). It has reached Phase II clinical trials for the treatment of diabetic nephropathy and nonalcoholic steatohepatitis.




See also


GSK-4112
SR9009
SR9011




References

Kata Kunci Pencarian:

• Nidufexor
• Ivermectin
• Bile acid
• SR9011
• Chenodeoxycholic acid
• Obeticholic acid
• Cafestol
• Efavirenz
• Fexaramine
• Farnesoid X receptor